Recent Events & Catalysts
Iovance Biotherapeutics, Inc. (IOVA) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $13
Benzinga · 4d ago
Citizens Maintains Market Outperform on Iovance Biotherapeutics, Raises Price Target to $8
Benzinga · 4d ago
Top stock movements in today's session.
ChartMill · 5d ago
Let's uncover which stocks are experiencing notable gaps during today's session.
ChartMill · 5d ago
Iovance: Stock Soars On Q2 Earnings - Critical Data In Melanoma, NSCLC Due September
SeekingAlpha · 5d ago
Iovance (IOVA) Stock Soars After Better-Than-Expected Q2 Results
Benzinga · 5d ago
Iovance Biotherapeutics (NASDAQ:IOVA) Beats Q2 Estimates on Record Revenue, Shares Jump
ChartMill · 5d ago
Iovance Biotherapeutics, Inc. (IOVA) Q2 2026 Earnings Call Transcript
SeekingAlpha · 5d ago
SEC Filings (90 days)
Other events, Financial statements and exhibits
Filed 2026-08-06 · 5d ago
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-06 · 5d ago · Material
Other events, Financial statements and exhibits
Filed 2026-07-02 · 40d ago
Submission of matters to a vote of security holders, Other events, Financial statements and exhibits
Filed 2026-06-10 · 62d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.